Stock MET.PRA METLIFE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings MetLife, Inc. Nyse

Equities

MET.PRA

US59156R5046

Market Closed - Nyse
Other stock markets
 21:10:00 07/06/2024 BST 		5-day change 1st Jan Change
24.62 USD -0.16% Intraday chart for MetLife, Inc. -0.28% +6.81%
05-31 Sector Update: Financial Stocks Rise Late Afternoon MT
05-31 Sector Update: Financial MT

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
METLIFE, INC. Stock MetLife, Inc.
+6.81% 49.81B -
AXA Stock AXA
+12.51% 78.94B
B-
AFLAC INCORPORATED Stock Aflac Incorporated
+7.62% 50.45B
B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+21.55% 46.31B
B+
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+13.62% 42.31B
B+
GENERALI Stock Generali
+24.52% 39.83B
B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
-1.75% 28.46B
B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-8.98% 27.07B
B-
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+27.21% 26.32B
A
DAI-ICHI LIFE HOLDINGS, INC. Stock Dai-ichi Life Holdings, Inc.
+34.36% 24.17B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MET Stock
  4. MET.PRA Stock
  5. Ratings MetLife, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW